161 related articles for article (PubMed ID: 24371266)
21. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
Charpentier E; Richter H; van der Oost J; White MF
FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
[TBL] [Abstract][Full Text] [Related]
22. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.
Richter C; Chang JT; Fineran PC
Viruses; 2012 Oct; 4(10):2291-311. PubMed ID: 23202464
[TBL] [Abstract][Full Text] [Related]
23. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas12a System for Biosensing and Gene Regulation.
Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
Osawa T; Inanaga H; Numata T
J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
[TBL] [Abstract][Full Text] [Related]
26. Coupling transcriptional activation of CRISPR-Cas system and DNA repair genes by Csa3a in Sulfolobus islandicus.
Liu T; Liu Z; Ye Q; Pan S; Wang X; Li Y; Peng W; Liang Y; She Q; Peng N
Nucleic Acids Res; 2017 Sep; 45(15):8978-8992. PubMed ID: 28911114
[TBL] [Abstract][Full Text] [Related]
27. Anti-CRISPR AcrIE2 Binds the Type I-E CRISPR-Cas Complex But Does Not Block DNA Binding.
Mejdani M; Pawluk A; Maxwell KL; Davidson AR
J Mol Biol; 2021 Feb; 433(3):166759. PubMed ID: 33338493
[TBL] [Abstract][Full Text] [Related]
28. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.
Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP
Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008
[TBL] [Abstract][Full Text] [Related]
29. Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation.
Musharova O; Klimuk E; Datsenko KA; Metlitskaya A; Logacheva M; Semenova E; Severinov K; Savitskaya E
Nucleic Acids Res; 2017 Apr; 45(6):3297-3307. PubMed ID: 28204574
[TBL] [Abstract][Full Text] [Related]
30. Decoupling the bridge helix of Cas12a results in a reduced trimming activity, increased mismatch sensitivity and impaired conformational transitions.
Wörle E; Jakob L; Schmidbauer A; Zinner G; Grohmann D
Nucleic Acids Res; 2021 May; 49(9):5278-5293. PubMed ID: 34009379
[TBL] [Abstract][Full Text] [Related]
31. Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b.
Richter H; Rompf J; Wiegel J; Rau K; Randau L
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2993-3000. PubMed ID: 28238733
[TBL] [Abstract][Full Text] [Related]
32. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
Chylinski K; Le Rhun A; Charpentier E
RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
[TBL] [Abstract][Full Text] [Related]
33. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
[TBL] [Abstract][Full Text] [Related]
34. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.
Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A
RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
36. Molecular recordings by directed CRISPR spacer acquisition.
Shipman SL; Nivala J; Macklis JD; Church GM
Science; 2016 Jul; 353(6298):aaf1175. PubMed ID: 27284167
[TBL] [Abstract][Full Text] [Related]
37. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.
Walker FC; Chou-Zheng L; Dunkle JA; Hatoum-Aslan A
Nucleic Acids Res; 2017 Feb; 45(4):2112-2123. PubMed ID: 28204542
[TBL] [Abstract][Full Text] [Related]
38. Structure of the archaeal Cascade subunit Csa5: relating the small subunits of CRISPR effector complexes.
Reeks J; Graham S; Anderson L; Liu H; White MF; Naismith JH
RNA Biol; 2013 May; 10(5):762-9. PubMed ID: 23846216
[TBL] [Abstract][Full Text] [Related]
39. Multifactorial control of the expression of a CRISPR-Cas system by an extracytoplasmic function σ/anti-σ pair and a global regulatory complex.
Bernal-Bernal D; Abellón-Ruiz J; Iniesta AA; Pajares-Martínez E; Bastida-Martínez E; Fontes M; Padmanabhan S; Elías-Arnanz M
Nucleic Acids Res; 2018 Jul; 46(13):6726-6745. PubMed ID: 29893914
[TBL] [Abstract][Full Text] [Related]
40. Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target Flexibility.
Ratner HK; Weiss DS
J Bacteriol; 2020 May; 202(12):. PubMed ID: 32284320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
